Evidence map›Paper›PMID 37464022›Full record

ArticleInternational journal of impotence research2024

Correction: Peyronie's Disease Questionnaire (PDQ): Spanish translation and validation.

Borja García-Gómez, Juan Ignacio Martínez-Salamanca, Joaquim Sarquella-Geli, Juan Justo-Quintas, Esther García-Rojo, Esaú Fernández-Pascual, Eduard Ruíz-Castañé, Javier Romero-Otero

Registry-linked trialAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in International journal of impotence research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06621420 (Peyronie Disease Questionnaire), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06621420 unknown statusnot on this map

Peyronie Disease Questionnaire (PDQ): Turkish Validation

TypeobservationalSponsorAcibadem UniversityRan2024 to 2025Enrolled60ConditionsPeyronie Disease
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Borja García-GómezUrology Department, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.ORCID http://orcid.org/0000-0003-1071-3656
Juan Ignacio Martínez-SalamancaLyx Instituto de Urología, Universidad Francisco de Vitoria, Madrid, Spain.
Joaquim Sarquella-GeliAndrology Department, Fundació Puigvert, Barcelona, Spain.
Juan Justo-QuintasUrology Department, Hospital HM Montepríncipe, Madrid, Spain.
Esther García-RojoUrology Department, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Esaú Fernández-PascualLyx Instituto de Urología, Universidad Francisco de Vitoria, Madrid, Spain.ORCID http://orcid.org/0000-0002-2602-2617
Eduard Ruíz-CastañéAndrology Department, Fundació Puigvert, Barcelona, Spain.
Javier Romero-OteroUrology Department, Hospital HM Montepríncipe, Madrid, Spain. jromerootero@hotmail.com.ORCID http://orcid.org/0000-0002-0666-5105

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.